SCHEMBL8808373

SCHEMBL8808373

O=C1CCc2cc(N3CCC(O)CC3)c(Cl)cc2N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 11/20 0.39
▸ HTR1A P08908 2/20 0.38
▸ HTR2A P28223 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ HTR3E A5X5Y0 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MLNR O43193 1/20 0.37
▸ HTR3B O95264 1/20 0.37
▸ ABCB11 O95342 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ PGR P06401 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ ABCB1 P08183 1/20 0.37
▸ ADRB1 P08588 1/20 0.37
▸ ADRA2A P08913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8805728 0.84 LMNA (0.44) DRD2LMNAHTTSMN1; SMN2MAPT
SCHEMBL8805822 0.84 LMNA (0.42) DRD2HTR1AHTR2ALMNAHTT
SCHEMBL8805609 0.84 HSP90AA1 (0.37) LMNAHTTSMN1; SMN2MAPTMEN1
SCHEMBL8805973 0.81 PDE3B (0.43) DRD2LMNAHTTSMN1; SMN2MAPT
SCHEMBL8806081 0.81 DRD2 (0.42) DRD2HTR2ALMNAHTTSMN1; SMN2
SCHEMBL8806549 0.80 MAPT (0.51) LMNAHTTMAPTGAAMEN1
SCHEMBL8805823 0.79 CRBN (0.44) DRD2HTTMAPTPGRDRD4
SCHEMBL8807339 0.76 SLC6A4 (0.52) HTR1APGRSLC6A2SLC6A4SLC6A3
SCHEMBL8805917 0.74 DRD2 (0.37) DRD2HTR1AHTR2AMAPTGAA
SCHEMBL19278654 0.73 CA9 (0.52) PKMCA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583136-B1 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders KISSEI PHARMACEUTICAL (JP) 1997-10-08 — — EP disclosed
US-5294718-A Platelet aggregation inhibitors; antiischemic agents; side effect reduction KISSEI PHARMACEUTICAL CO., LTD. (JP) 1994-03-15 — — US disclosed
EP-0583136-A2 Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders Kissei Pharmaceutical Co., Ltd. (JP) 1994-02-16 — — EP disclosed
Send feedback